Guardion Health Sciences, a US-based ocular health sciences company and its recently acquired subsidiary NutriGuard, have been contracted by Malaysia’s Ho Wah Genting Berhad (HWGB) to design, develop and manufacture a proprietary immune support nutraceutical formula for the latter’s exclusive use. It will be producer under a brand name which is to be determined at a later date.
HWGB is a listed company in Malaysia with operations in the Manufacturing of electronics parts for local and export markets, as well as and travel and tour services.
Guardion develops, formulates, manufacture and distributes condition-specific Medical foods supported by evidence-based protocols. NutriGuard formulates high-quality, scientifically credible nutraceuticals, which are designed to supplement consumers’ diets and assist in the prevention and management of an array of diseases and conditions.
According to Dato’ Aaron Lim, the Group CEO of HWGB, the company has requested for the formulation to be made to meet the demands of its customers for an immune-supportive product, and look forward to introducing this much-needed product to the market. The formula is designed to boost type 1 interferon response to RNA viruses. Boosting type 1 interferon response is believed to blunt the replication of virus cells. The formula is designed to provide both immuno-supportive and anti-inflammatory benefits to its users. The press release from Guardion clarifies that the formula has not been used nor tested, nor is it intended to specifically address symptoms of the current COVID-19 virus.
(Sources: Guardion Health; The Edge Markets)